• 1. Picrotoxane sesquiterpenoids: chemistry, chemo- and bio-syntheses and biological activities
  Qiang-Qiang Shi,Jiang-Jiang Tang,Jin-Ming Gao Nat. Prod. Rep. 2022 39 2096
• 2. 174. Picrotoxinin and tutin. Part III. The hydrogenation of picrotoxinin
  S. N. Slater J. Chem. Soc. 1949 806
• 3. 922. Picrotoxin and tutin. Part VIII
  R. B. Johns,S. N. Slater,R. J. Woods,D. Brasch,Roy Gee J. Chem. Soc. 1956 4715
• 4. 428. Picrotoxin and tutin. Part VI. Methylation and methanolysis
  J. C. Benstead,Roy Gee,R. B. Johns,M. Martin-Smith,S. N. Slater J. Chem. Soc. 1952 2292
• 5. 185. Picrotoxin and tutin. Part IV. The reducing properties and functional groups
  J. C. Benstead,H. V. Brewerton,J. R. Fletcher,M. Martin-Smith,S. N. Slater,A. T. Wilson J. Chem. Soc. 1952 1042

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Furopyrans Furopyrans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Furopyrans

Picrotoxinin: A Comprehensive Overview

Picrotoxinin, also known as CAS No. 17617-45-7, is a naturally occurring compound that has garnered significant attention in the fields of pharmacology and toxicology. This compound is primarily found in certain plant species and has been extensively studied for its biological activities and potential applications in medicine and research.

Picrotoxinin is a sesquiterpenoid lactone, a class of compounds known for their diverse biological properties. Its chemical structure, characterized by a unique arrangement of oxygen atoms and a lactone ring, contributes to its potent pharmacological effects. Recent studies have highlighted its role as a neurotoxin, particularly in its ability to induce seizures in experimental models. This property has led researchers to explore its mechanisms of action and potential therapeutic uses.

One of the most notable aspects of Picrotoxinin is its interaction with ion channels, particularly the GABAA receptor complex. Studies have shown that it enhances the activity of GABAA receptors, leading to increased chloride ion influx into neurons. This effect has been linked to its convulsant properties, as excessive neuronal excitation can trigger seizures. However, this same mechanism has also raised interest in its potential use as a tool for studying epilepsy and other neurological disorders.

Recent advancements in analytical techniques have allowed for a deeper understanding of Picrotoxinin's pharmacokinetics and metabolism. Researchers have identified key enzymes involved in its biotransformation, shedding light on how it is processed within the body. This knowledge is crucial for developing strategies to mitigate its toxic effects while maximizing its therapeutic potential.

In terms of applications, Picrotoxinin has been utilized as a research tool in neuropharmacology due to its ability to modulate neuronal activity. It has been employed in preclinical studies to investigate the pathophysiology of epilepsy and other seizure-related conditions. Additionally, its unique chemical structure makes it a valuable compound for drug discovery efforts aimed at developing novel antiepileptic agents.

Despite its promising applications, the toxicity profile of Picrotoxinin remains a critical area of investigation. Studies have demonstrated that it can cause adverse effects at higher doses, including neurotoxicity and hepatotoxicity. Understanding these effects is essential for ensuring safe use in both research and clinical settings.

Recent collaborative efforts between academic institutions and pharmaceutical companies have led to breakthroughs in synthesizing analogs of Picrotoxinin with improved safety profiles. These analogs are being tested for their efficacy in treating refractory epilepsy, a condition that currently lacks effective treatment options.

In conclusion, Picrotoxinin (CAS No. 17617-45-7) is a compound with significant scientific and therapeutic potential. Its unique pharmacological properties, coupled with ongoing research advancements, position it as a key player in the development of novel treatments for neurological disorders. As our understanding of this compound continues to grow, so too does its promise as a valuable tool in medicine and neuroscience.

• 149182-86-5(7,10,23,26-Tetraoxapentacyclo[26.4.0.05,32.012,17.016,21]dotriacontane-8,24-dione,1,5,17,21-tetramethyl-13,29-bis(methylene)-9,25-bis[(2S)-tetrahydro-2-oxo-3-furanyl]-,(1S,5R,9R,12S,16R,17S,21R,25R,28S,32R)- (9CI))
• 35481-77-7(3,6-Methano-2,4,7-trioxacyclopenta[cd]cycloprop- [a]azulen-5(1H)-one,octahydro-6a,7bdihydroxy- 7c-methyl-8-(1-methylethenyl)-,(2aS,3R,6S,6aR,6bS,7aR,7bR,7cS,8R)-)
• 2749-28-2(Spiro[2,5-methano-7H-oxireno[3,4]cyclopent[1,2-d]oxepin-7,2'-oxiran]-3(2H)-one,6-(acetyloxy)hexahydro-1b-hydroxy-6a-methyl-8-(1-methylethenyl)-,(1aS,1bR,2S,2'R,5R,6S,6aR,7aR,8R)-)
• 108887-44-1(3,6-Methano-2,4,7-trioxacyclopenta[cd]cycloprop[a]azulen-5(1H)-one,7b-(acetyloxy)octahydro-6a-hydroxy-7c-methyl-8-(1-methylethenyl)-, [2aS-(2aa,3a,6a,6aa,6bb,7ab,7ba,7ca,8S*)]- (9CI))
• 24462-32-6(Pretoxin)
• 79029-98-4(coriaria lactone)
• 2571-86-0(Coriamyrtin)
• 21412-42-0(methyl (1aS,1bR,2R,3R,4R,5R,5aR,6aR)-3,5a-dihydroxy-1b-methyl-7-oxo-4-(prop-1-en-2-yl)octahydro-1aH-2,5-(epoxymethano)indeno[1,2-b]oxirene-1a-carboxylate)
• 21412-41-9(2,5-Ethanooxireno[4,5]cyclopenta[1,2-c]pyran-1a(2H)-carboxylic acid, hexahydro-5a,8-dihydroxy-1b-methyl-7-(1-methylethenyl)-4-oxo- (9CI))
• 89307-60-8(2-Oxiranecarboxylic acid, 3-[(2,2-dimethyl-6-methylenecyclohexyl)methyl]-2-methyl-, ethyl ester)